NZ504525A - Use of cetyl alcohol esters of myristic and palmitic acids to treat eczema and psoriasis - Google Patents

Use of cetyl alcohol esters of myristic and palmitic acids to treat eczema and psoriasis

Info

Publication number
NZ504525A
NZ504525A NZ50452500A NZ50452500A NZ504525A NZ 504525 A NZ504525 A NZ 504525A NZ 50452500 A NZ50452500 A NZ 50452500A NZ 50452500 A NZ50452500 A NZ 50452500A NZ 504525 A NZ504525 A NZ 504525A
Authority
NZ
New Zealand
Prior art keywords
psoriasis
myristic
cetyl alcohol
alcohol esters
palmitic acids
Prior art date
Application number
NZ50452500A
Inventor
Timothy David Meakin
Craig Leonard Heatley
Dianne Cadwallader
Original Assignee
Meracol Corp Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meracol Corp Ltd filed Critical Meracol Corp Ltd
Priority to NZ50452500A priority Critical patent/NZ504525A/en
Priority to US10/275,269 priority patent/US20030153620A1/en
Priority to PCT/NZ2001/000085 priority patent/WO2001085163A1/en
Priority to ES01934672T priority patent/ES2298237T3/en
Priority to EP01934672A priority patent/EP1335719B1/en
Priority to AU6083301A priority patent/AU6083301A/en
Priority to CA002408541A priority patent/CA2408541C/en
Priority to AT01934672T priority patent/ATE381327T1/en
Priority to AU2001260833A priority patent/AU2001260833B2/en
Priority to DE60132008T priority patent/DE60132008T2/en
Publication of NZ504525A publication Critical patent/NZ504525A/en
Priority to US11/056,008 priority patent/US8147851B2/en
Priority to CY20081100293T priority patent/CY1107242T1/en
Priority to US13/405,203 priority patent/US8535696B2/en
Priority to US13/753,279 priority patent/US8586064B2/en

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The use of a mixture of cetyl myristate and cetyl palmitate to treat eczema and/or psoriasis.
NZ50452500A 2000-05-12 2000-05-12 Use of cetyl alcohol esters of myristic and palmitic acids to treat eczema and psoriasis NZ504525A (en)

Priority Applications (14)

Application Number Priority Date Filing Date Title
NZ50452500A NZ504525A (en) 2000-05-12 2000-05-12 Use of cetyl alcohol esters of myristic and palmitic acids to treat eczema and psoriasis
AT01934672T ATE381327T1 (en) 2000-05-12 2001-05-11 CETHYL MYRISTATE AND CETYL PALMITATE FOR THE TREATMENT OF ECZEMA AND/OR PSORIASIS
AU2001260833A AU2001260833B2 (en) 2000-05-12 2001-05-11 Treating eczema and/or psoriasis
ES01934672T ES2298237T3 (en) 2000-05-12 2001-05-11 CETIL MIRISTATO AND CETIL PALMITATO FOR THE TREATMENT OF ECZEMA AND / OR SORIASIS.
EP01934672A EP1335719B1 (en) 2000-05-12 2001-05-11 Cetyl myristate and cetyl palmitate for treating eczema and/or psoriasis
AU6083301A AU6083301A (en) 2000-05-12 2001-05-11 Treating eczema and/or psoriasis
CA002408541A CA2408541C (en) 2000-05-12 2001-05-11 Treating eczema and/or psoriasis
US10/275,269 US20030153620A1 (en) 2000-05-12 2001-05-11 Treating eczema and/or psoriasis
PCT/NZ2001/000085 WO2001085163A1 (en) 2000-05-12 2001-05-11 Treating eczema and/or psoriasis
DE60132008T DE60132008T2 (en) 2000-05-12 2001-05-11 CYTYLMYRISTATE AND CETYLPALMITATE FOR THE TREATMENT OF ECCEMENTS AND / OR PSORIASIS
US11/056,008 US8147851B2 (en) 2000-05-12 2005-02-14 Treating eczema and/or psoriasis
CY20081100293T CY1107242T1 (en) 2000-05-12 2008-03-17 OXYGEN AND PULMONY FOR A TREATMENT OF ECZEMA AND / OR SPORTS
US13/405,203 US8535696B2 (en) 2000-05-12 2012-02-24 Treating eczema and/or psoriasis
US13/753,279 US8586064B2 (en) 2000-05-12 2013-01-29 Treating eczema and/or psoriasis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NZ50452500A NZ504525A (en) 2000-05-12 2000-05-12 Use of cetyl alcohol esters of myristic and palmitic acids to treat eczema and psoriasis

Publications (1)

Publication Number Publication Date
NZ504525A true NZ504525A (en) 2003-01-31

Family

ID=19927881

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ50452500A NZ504525A (en) 2000-05-12 2000-05-12 Use of cetyl alcohol esters of myristic and palmitic acids to treat eczema and psoriasis

Country Status (1)

Country Link
NZ (1) NZ504525A (en)

Similar Documents

Publication Publication Date Title
ES2148223T3 (en) TAXOL ENCAPSULATED IN LIPOSOMES AND METHOD FOR USE.
HK1005985A1 (en) Combined use of hyaluronic acid and therapeutic agents to improve the therapeutic effect
ES2165997T3 (en) USE OF A PEDIATRIC PHARMACEUTICAL FORMULATION THAT INCLUDES AMOXYCLINE AND CLAVULANATE.
DE60108154D1 (en) Pharmaceutical preparations containing clavulanic acid
DK1313511T3 (en) Testosterone ester formulation for human use
FI99051C (en) Method and coupling to facilitate supply of fuel to the pressurized space
MY114765A (en) Preparation for epidermis
ES2110572T3 (en) COSMETIC COMPOSITION CONTAINING A LIPIDO AND A HYDROXY OR CETOCARBOXILICO ACID.
HK1131912A1 (en) Pharmaceutical compositions and methods useful for modulating angiogenesis
GR3023038T3 (en) Use of coconut precursor fatty acid as insect-repellent.
ES2111355T3 (en) L-CARNITINE SALT AND COSMETIC AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN IT FOR THE TREATMENT OF DERMATOSIS.
IL150125A0 (en) Novel compounds
ATE172108T1 (en) USE OF DIGLYCERIN ESTERS AGAINST IMPUREE SKIN
BG104470A (en) The use of a mixture of a diol and an alpha-hydroxy acid for the treatment of hyperkeratotic skin diseases
DE59208362D1 (en) LANOL DERIVATIVES AS PENETRATION-PROMOTING SUBSTANCES
DE69526350D1 (en) ABSCHUPPUNGS COMPOSITION
BR0007952A (en) Hair treatment agent
NZ504525A (en) Use of cetyl alcohol esters of myristic and palmitic acids to treat eczema and psoriasis
BR0107211A (en) Agent for treating hepatitis c
AU7735298A (en) Use of C18 to C26 aliphatic alcohols for the manufacture of medicament in the t reatment of hyperproliferative skin disorders
BG104029U (en) Formulation for the treatment of dermatozoonoses
IT1270177B (en) Detergent, emollient and hydrating composition for use as an auxiliary in the hygienic treatment of blepharitis
UA30393A (en) Method for treating coronal atherosclerosis
UA15302C2 (en) ANTI-INFLAMMATORY AND MEDICINAL MEDICINAL PRODUCT
IT1255639B (en) USE OF OXATOMIDE AS AN AGED AGENT

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)
ASS Change of ownership

Owner name: LYPANOSYS PTE LIMITED, SG

Free format text: OLD OWNER(S): MERACOL CORPORATION LIMITED

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 7 YEARS UNTIL 11 MAY 2021 BY LEA SKYLLERSTEDT

Effective date: 20140430

EXPY Patent expired